« Back
Home /
Gemtuzumab ozogamicin

Gemtuzumab ozogamicin

€5,756.00

Excl. VAT

Item no.	HY-109539-500ug
Manufacturer	MedChem Express
CASRN	220578-59-6
Amount	500 ug
Category	Antibodies Primary Antibodies
Type	Antibody
Specific against	other
Purity	98.00
Citations	[1]Baron J, et al. Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia. Expert Rev Clin Pharmacol. 2018;11(6):549-559.
Smiles	[Gemtuzumab ozogamicin]
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Available
Product Description	Gemtuzumab ozogamicin is an antibody-drug conjugate (ADC) consisting of a cytotoxic derivative of Calicheamicin, and a monoclonal antibody targeting CD33 antigen, which present on leukemic myeloblasts of acute myeloid leukemia (AML). Calicheamicin is a cytotoxic antibiotic. Gemtuzumab ozogamicin can be used for the research of acute myeloid leukemia[1].
StorageTemperature	4°C (Powder, sealed storage, away from moisture and light)
Shipping	Room Temperature
Manufacturers Applications	Cancer-programmed cell death
Molecular Weight	N/A
Clinical Information	Launched
Solubility	H2O
Pathway	Antibody-drug Conjugate/ADC Related
Manufacturers Product type	ADC Related

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

Listprice: €5,756.00

Price: €5,756.00

available

Quantity:

Compare

Add to wishlist